Clinical Trial Update: ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ERC1671 in combination with GM-CSF and cyclophosphamide for glioblastoma multiforme and gliosarcoma. The study is active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• ERC1671
• GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Epitopoietic Research Corporation | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING